What does vaccination development look like from a risk-based perspective? Seth Guikema, Ph.D., University of Michigan, talks with Ben Trump, a member of the Army Corps of Engineers, about the complex process of COVID-19 vaccine development. Between accounting for technical science perspectives, considering various forms of regulatory approval, and addressing risk assessment-based challenges, parsing through the process for COVID-19 emergency use vaccination efforts can seem arduous. Disclaimer: Opinions are the speakers' alone, and not representative of the US Government or any state government.